Company: SYRA
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001641172-25-023235
Chunk: 1

Company: Syra Health Corp
Filing Date: 2025-08-12
Form: 10-Q
Item: Item 1
Chunk 1
---
 2025 and December 31, 2024, respectively 
     11,339  
     8,979 
  
    Convertible class B common stock, $0.001 par value, 5,000,000 shares authorized, 600,000 and 833,334 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively 
     600  
     833 
  
    Common stock, value 
     600  
     833 

    Additional paid-in capital 
     11,762,278  
     11,692,952 
  
    Accumulated deficit 
     (9,360,054) 
     (8,824,193)
  
    Total stockholders’ equity (deficit) 
     2,414,163  
     2,878,571 

    Total liabilities and stockholders’ equity (deficit) 
    $3,471,462  
    $3,679,332 

See
accompanying notes to condensed unaudited financial statements.

F-1

SYRA
HEALTH CORP.

CONDENSED
STATEMENTS OF OPERATIONS

(Unaudited)

    2025  
    2024  
    2025  
    2024 

    For the Three Months Ended  
    For the Six Months Ended 

    2025  
    2024  
    2025  
    2024 

    Net revenues 
    $1,946,199  
    $1,969,681  
    $3,803,973  
    $3,722,021 
  
    Cost of services 
     1,193,304  
     1,619,674  
     2,461,922  
     3,192,727 
  
    Gross profit 
     752,895  
     350,007  
     1,342,051  
     529,294 

    Operating expenses: 

    Salaries and benefits 
     326,354  
     847,064  
     833,561  
     1,583,367 
  
    Professional services 
     164,939  
     141,456  
     388,965  
     336,036